REQUEST A DEMO
Total
USD $0.00
Search more companies

G & T Pharma Sdn. Bhd. (Malaysia)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers | Lessors of Other Real Estate Property
Full name: G & T Pharma Sdn. Bhd. Profile Updated: February 05, 2024
Buy our report for this company USD 19.99 Most recent financial data: 2023 Available in: English Download a sample report

G & T Pharma Sdn. Bhd. is based in Malaysia. The head office is in Perai. The company operates in the Drugs and Druggists' Sundries Merchant Wholesalers industry. It was incorporated on August 02, 2018. The latest financial highlights indicate a net sales revenue increase of 46.69% in 2023. Over the same period, its total assets decreased by 3.4%. In 2023, G & T Pharma Sdn. Bhd.’s net profit margin increased by 1.3%.

Headquarters
No. 39 & 41 (Ground Floor), Jalan Todak 6,, Pusat Komersial Sunway Perdana,
Perai; Penang; Postal Code: 13700

Contact Details: Purchase the G & T Pharma Sdn. Bhd. report to view the information.

Basic Information
Outstanding Shares:
Purchase the G & T Pharma Sdn. Bhd. report to view the information.
Financial Auditors:
Purchase the G & T Pharma Sdn. Bhd. report to view the information.
Incorporation Date:
August 02, 2018
Key Executives
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Secretary
Purchase this report to view the information.
Secretary
Ownership Details
Purchase this report to view the information.
80%
Purchase this report to view the information.
20%
Company Performance
Financial values in the chart are available after G & T Pharma Sdn. Bhd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency MYR. Absolute financial data is included in the purchased report.
Net sales revenue
46.69%
Total operating revenue
46.69%
Operating profit (EBIT)
108%
EBITDA
132.18%
Net Profit (Loss) for the Period
173.29%
Total assets
-3.4%
Total equity
628.59%
Operating Profit Margin (ROS)
0.63%
Net Profit Margin
1.3%
Return on Equity (ROE)
-39.94%
Quick Ratio
0.61%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?